Education
About Us
Working with TipRanks
Follow Us
biote (BTMD)
NASDAQ:BTMD
BTMD Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.04 - $8.44
Previous CloseN/A
Volume19.10K
Average Volume (3M)266.27K
Market Cap
$198.60M
Enterprise Value$374.57M
Total Cash (Recent Filing)$89.00M
Total Debt (Recent Filing)$114.87M
Price to Earnings (P/E)19.2
Beta1.50
Next Earnings
May 13, 2025EPS Estimate
0.08Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.18
Shares Outstanding33,073,277
10 Day Avg. Volume227,988
30 Day Avg. Volume266,266
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)1.07
Price to Cash Flow (P/CF)4.30
P/FCF Ratio4.70
Enterprise Value/Market Cap1.89
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit2.69
Enterprise Value/Ebitda22.28
Forecast
1Y Price Target
$7.36Price Target Upside112.72% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering6
---
Bulls Say, Bears Say
Bulls Say
Leadership StrategyWith the new CEO at the helm, BTMD will focus on refining execution around creating higher efficiency with existing clinics and acquiring/onboarding new clinics.
Market OpportunityThe market opportunity remains attractive and the end consumer remains loyal to BTMD's products even in a choppy macro backdrop.
Bears Say
Sales Force AllocationNew clinic growth suffered during the quarter as the sales force was dedicated to top-tier clinics to smooth the transition to the new software.
Software TransitionOngoing software transition issues will linger, and it will likely take 2+ quarters for trends to start to show improvement.
---
Ownership Overview
67.37% Insiders
12.52% Mutual Funds
0.17% Other Institutional Investors
11.69% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
BTMD FAQ
What was biote’s price range in the past 12 months?
biote lowest stock price was $3.04 and its highest was $8.44 in the past 12 months.
What is biote’s market cap?
biote’s market cap is $198.60M.
When is biote’s upcoming earnings report date?
biote’s upcoming earnings report date is May 13, 2025 which is in 39 days.
How were biote’s earnings last quarter?
biote released its earnings results on Mar 12, 2025. The company reported $0.1 earnings per share for the quarter, missing the consensus estimate of $0.114 by -$0.014.
Is biote overvalued?
According to Wall Street analysts biote’s price is currently Undervalued.
Does biote pay dividends?
biote does not currently pay dividends.
What is biote’s EPS estimate?
biote’s EPS estimate is 0.08.
How many shares outstanding does biote have?
biote has 33,073,277 shares outstanding.
What happened to biote’s price movement after its last earnings report?
biote reported an EPS of $0.1 in its last earnings report, missing expectations of $0.114. Following the earnings report the stock price went down -25.122%.
Which hedge fund is a major shareholder of biote?
Currently, no hedge funds are holding shares in BTMD
---
biote Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$7.36 (112.72% Upside)
$7.36 (112.72% Upside)
Blogger Sentiment
Bullish
BTMD Sentiment 100%
Sector Average 69%
Sector Average 69%
Hedge Fund Trend
Decreased
By 1.0K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $4.1M over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 2.0%
Last 30 Days ▲ 14.0%
Last 30 Days ▲ 14.0%
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-40.03%
12-Months-Change
Fundamentals
Return on Equity
-7.92%
Trailing 12-Months
Asset Growth
-21.20%
Trailing 12-Months
Company Description
biote
biote Corp. operates in medical practice-building business within the hormone optimization space. The company offers a platform for Biote-certified practitioners to optimize imbalances in their patient's hormone, vitamin, and mineral levels, as well as prescribe bioidentical hormone therapies and recommend dietary supplements. It also sells Biote-branded dietary supplements; and sterile pellet insertion kits for men and women. The company was founded in 2011 and is headquartered in Irvine, Texas.
---
BTMD Earnings Call
Q4 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call highlighted several positive aspects, such as revenue growth, improved gross profit margins, and successful integration of acquisitions. However, these were countered by notable challenges, including a decline in net income, slowed new customer growth, increased SG&A expenses, and modest procedural revenue growth expectations. The balance of positive and negative elements results in a neutral sentiment.Read More>---
BTMD Stock 12 Month Forecast
Average Price Target
$7.36
▲(112.72% Upside)
Technical Analysis
Best Analysts Covering BTMD
1 Year
1 Year Success Rate
3/10 ratings generated profit
1 Year Average Return
-12.80%
reiterated a buy rating 23 days ago
Copying George Kelly's trades and holding each position for 1 Year would result in 30.00% of your transactions generating a profit, with an average return of -12.80% per trade.
---